National Sales Training Meetings - thoughts?????

[Anonymous]

Really, u r a dumb ass! Wake Up!

 

[Anonymous]

We shouldn't get our hopes up that Incresync will get approved. No way will FDA approve it, TZD class doesn't meet the safety criteria of the FDA.

If Actos and the new DPPIVi used bioequivalent studies to get the combination approved, how can the FDA not approve Incresync based on the Pioglitazone portion of the drug without removing Actos from the market?

 

[Anonymous]

If Actos and the new DPPIVi used bioequivalent studies to get the combination approved, how can the FDA not approve Incresync based on the Pioglitazone portion of the drug without removing Actos from the market?

Ask Novartis why their gout drug wasn't approved. It wasn't better than current therapeutic options. How will this combination drug be better and more cost effective than the current line up of DPP4's and generic Actos?

 

[Anonymous]

Merck withdrew its sitagliptin/pioglitazone combo application in the European Union.

 

[Anonymous]

HELLO!!!! Pioglitazone has been shown to cause some really bad shit in humans. Do you think any company wants to use it in a combo product? WTF?

 

[Anonymous]

HELLO!!!! Pioglitazone has been shown to cause some really bad shit in humans. Do you think any company wants to use it in a combo product? WTF?

Yeah, those significant A1C drops are brutal.